VANGL2 and neoplasm: While the loss of Vangl2 significantly reduces both metastatic burden and number of metastatic lesions, it does not appear to impact the efficiency with which disseminated tumor cells colonize the lung nor the proliferation of established metastatic lesions, suggesting that Vangl2 may be mediating local migration and invasion from the primary tumor.